Bausch Lomb Other Liab Over Time
| BLCO Stock | USD 19.82 0.15 0.75% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Bausch Lomb Performance and Bausch Lomb Correlation. Bausch |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Lomb. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Lomb listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.89) | Earnings Share (1.04) | Revenue Per Share 13.327 | Quarterly Revenue Growth 0.188 | Return On Assets 0.0089 |
The market value of Bausch Lomb Corp is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Lomb's value that differs from its market value or its book value, called intrinsic value, which is Bausch Lomb's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Lomb's market value can be influenced by many factors that don't directly affect Bausch Lomb's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Lomb's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Lomb is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Lomb's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Other Liab Analysis
Compare Bausch Lomb Corp and related stocks such as Cooper Companies,, ICU Medical, and Hologic Other Liab Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COO | 18.6 M | 86.3 M | 66 M | 77.4 M | 111.8 M | 132.1 M | 137.5 M | 282.8 M | 272.7 M | 271.1 M | 304.3 M | 686.6 M | 615.1 M | 707.4 M | 742.7 M |
| ICUI | 2.9 M | 4.1 M | 3.3 M | 4.4 M | 2.7 M | 4.3 M | 4 M | 88.4 M | 72.4 M | 37.8 M | 18.1 M | 22.1 M | 244.7 M | 281.4 M | 295.5 M |
| HOLX | 9.2 M | 78.7 M | 160 M | 169.4 M | 1.4 B | 1.2 B | 1.1 B | 638.5 M | 419.8 M | 429.3 M | 662.3 M | 448.9 M | 321.5 M | 369.7 M | 441.1 M |
| BDX | 364.9 M | 1.4 B | 1 B | 1.3 B | 3.6 B | 3 B | 2.8 B | 6.8 B | 6.9 B | 6.9 B | 6.5 B | 5.9 B | 5.2 B | 6 B | 6.3 B |
| TFX | 106.4 M | 294.7 M | 299 M | 213.2 M | 277.1 M | 554.7 M | 475.8 M | 1.1 B | 1.1 B | 807.1 M | 812.1 M | 580.7 M | 580.1 M | 667.2 M | 439.9 M |
| WST | 25.5 M | 180.1 M | 173.7 M | 138.1 M | 136.3 M | 126 M | 132 M | 106.4 M | 102.9 M | 109.2 M | 117 M | 112.5 M | 113.2 M | 130.2 M | 107.9 M |
| ALC | 3 B | 3 B | 3 B | 3 B | 3 B | 3 B | 3 B | 2.5 B | 2.4 B | 2.6 B | 2.3 B | 2 B | 1.9 B | 1.7 B | 1.9 B |
| RMD | 4.1 M | 17.8 M | 15.5 M | 21.7 M | 27.4 M | 50.6 M | 69.5 M | 223.7 M | 220.6 M | 221.6 M | 172.6 M | 160 M | 315.2 M | 362.5 M | 380.6 M |
| AKYA | 9.4 M | 9.4 M | 9.4 M | 9.4 M | 9.4 M | 9.4 M | 9.4 M | 9.4 M | 9.4 M | 9.4 M | 8.7 M | 9.4 M | 8.2 M | 7.4 M | 7.1 M |
| ATRC | 84 K | 2.5 M | 1.3 M | 8.2 M | 149 K | 41.1 M | 41.9 M | 37.8 M | 19.4 M | 186.4 M | 187.4 M | 1.2 M | 1.2 M | 1.4 M | 1.3 M |
| HAE | 2.2 M | 21.6 M | 26.1 M | 37.6 M | 31.7 M | 47.5 M | 34.3 M | 40.8 M | 48.7 M | 38.2 M | 76.9 M | 108.6 M | 108.6 M | 124.9 M | 131.1 M |
| ANGO | 9.8 M | 327 K | 66.3 M | 56.5 M | 38.5 M | 47.9 M | 30.1 M | 19 M | 23.9 M | 39.6 M | 37.1 M | 24.2 M | 17.4 M | 20 M | 32.6 M |
| ATR | 14.9 M | 67.6 M | 102.3 M | 77.7 M | 114.1 M | 114.6 M | 116.9 M | 106.9 M | 139.7 M | 165.9 M | 251.7 M | 267.2 M | 122.5 M | 140.9 M | 99 M |
Bausch Lomb Corp and related stocks such as Cooper Companies,, ICU Medical, and Hologic Other Liab description
My Equities
My Current Equities and Potential Positions
| Bausch Lomb Corp | BLCO |
| Classification | Office Supplies |
| Location | British Columbia; Canada |
| Exchange | New York Stock Exchange |
USD 19.82
Check out Bausch Lomb Performance and Bausch Lomb Correlation. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Bausch Lomb technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.